A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)

NCT04630145 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)

Interventions

DRUG: Bedaquiline
DRUG: Clarithromycin
DRUG: Ethambutol
DRUG: Rifampicin
DRUG: Rifabutin

Sponsor

Janssen Pharmaceutical K.K.